The medtech developer exceeded Wall Street expectations across the board, reporting $19.5 billion in revenue for fiscal year ...

Smith+Nephew’s CEO confirmed this week that talks failed with Johnson & Johnson over an orthopedic megamerger with DePuy ...

At the TCT conference in San Diego, Medtronic and Recor Medical presented new findings from their rival treatments for high ...

Shareholders of Siemens and Siemens Healthineers will vote on the deconsolidation from Siemens during their annual meetings ...

The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood ...

The trial found earlier interventions with Edwards’ Sapien 3 TAVR implant brought fewer heart failure-related events after two years.

Flow Medical expects a first-in-human case "very soon" and an IDE submission in 2027, co-founder and CEO Jennifer Fried tells ...

The Vitalyst system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock.

The annual TCT conference in San Diego saw medtechs illustrate methods for controlling stroke, reestablishing coronaries and ...

LivaNova posted earnings ahead of Wall Street estimates as it plans to launch its neuromodulation platform for obstructive ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

In the last two quarters, we gained share and our competitive position improved. But we believe that we have reached a ...